NEW YORK, February 24, 2021 (GLOBE NEWSWIRE) – Pawar Law Group is issuing an on behalf of shareholders who purchased shares in Bluebird Bio, Inc. (NASDAQ: BLUE) from May 11, 2020 to November 4, 2020 Class Action known including (the “Class Period”). The lawsuit seeks to seek compensation for investors in bluebird bio, Inc. under federal securities laws.
To participate in the class action, go here or call Vik Pawar, Esq. toll free at 888-589-9804 or email email@example.com for information on the class action lawsuit.
According to the lawsuit, the defendants made false and / or misleading statements and / or did not disclose that: (1) data that would conflict with Bluebird’s US Biologics Licensing Application (“BLA”) filing for LentiGlobin for Sickle Cell Disease (” SCD ”), it was insufficient to demonstrate the comparability of drugs; (2) Defendants have downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the company’s BLA filing schedule for LentiGlobin for SCD, particularly with respect to manufacturing. (3) As a result of the foregoing, it was foreseeable that the Company would not file the BLA for LentiGlobin for SCD in the second half of 2021. and (4) as a result, the Company’s public statements at all relevant times have been materially false and misleading. When the real details hit the market, the lawsuit alleged that investors suffered damage.
If you want to appear as the lead plaintiff, you have to move the court at the latest April 13, 2021. A lead plaintiff is a representative party who acts on behalf of other class members in directing the dispute.
No class has been certified. Until a class is certified, you will not be represented by a lawyer unless you hire one. You can hire a lawyer of your choice. You also cannot do anything at this point and be an absent member of the class. Your ability to partake in a future recovery does not depend on whether you are the lead plaintiff.
The Pawar Law Group represents investors from all over the world. Lawyer advertising. Past results do not guarantee or forecast a similar result with respect to future matters.
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel .: (917) 261-2277
Fax: (212) 571-0938